FDA flags Abiomed’s latest recall as Impella pump woes continue
The recall comes as the latest in what has been a troubled time for Abiomed’s Impella catheters following the company’s acquisition by J&J in 2022.

The recall comes as the latest in what has been a troubled time for Abiomed’s Impella catheters following the company’s acquisition by J&J in 2022.
Paige specialises in developing AI applications, including the first FDA-cleared AI tool for pathology.
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
Zeiss’ AI-driven tool gets CE mark for OCT scans
Brain-computer interfaces are closer than you think
Olympus and Revival Healthcare team up to found GI robotics startup
Seegene launches new infectious disease analytics platform